ENTX · Entera Bio Ltd. Ordinary Shares
View on chartInsiders & Stakes
| Miranda Jayne Toledano Director | ▲ Buy | Grant | 847,135 Shares held | 7/14/2026 | View profile |
| Schwartz Phillip President of R&D | ▲ Buy | Open Market | 607,410 Shares held | 1/20/2022 | View profile |
| Gerald M. Lieberman Director | ▲ Buy | Grant | 338,454 Shares held | 1/1/2026 | View profile |
| Ellis Sean Director | ▲ Buy | Grant | 208,132 Shares held | 8/7/2026 | View profile |
| Burshtein Gregory Chief of R&D | ▲ Buy | Grant | 189,033 Shares held | 5/7/2026 | View profile |
| Yaacov-Garbeli Dana Chief Financial Officer | ▲ Buy | Grant | 171,441 Shares held | 5/7/2026 | View profile |
| Galitzer Hillel Chief Operating Officer | ▲ Buy | Grant | 163,566 Shares held | 5/7/2026 | View profile |
| Taitel Haya Director | ▲ Buy | Grant | 119,269 Shares held | 8/7/2026 | View profile |
| Malca Yonatan Director | ▲ Buy | Grant | 100,231 Shares held | 8/7/2026 | View profile |
| OSTROV GERALD M Director | ▲ Buy | Grant | 75,657 Shares held | 1/1/2026 | View profile |
| Germano Geno J Director | ▲ Buy | Grant | 65,014 Shares held | 8/7/2026 | View profile |
| Steven D. Rubin Director | ▲ Buy | Grant | 34,117 Shares held | 8/7/2026 | View profile |
| Ratan Ramesh U.S.based CFO | ▲ Buy | Open Market | 10,000 Shares held | 1/19/2022 | View profile |
| JAMAS SPIROS Chief Executive Officer | ▲ Buy | Open Market | 10,000 Shares held | 1/18/2022 | View profile |
| Mayron Ron Director | ▲ Buy | Open Market | 7,000 Shares held | 1/18/2022 | View profile |
Transaction History
| Steven D. Rubin | ▲ Buy | Grant | 19,117 | $0 | 8/7/2026 |
| Malca Yonatan | ▲ Buy | Grant | 22,815 | $0 | 8/7/2026 |
| Taitel Haya | ▲ Buy | Grant | 20,790 | $0 | 8/7/2026 |
| Ellis Sean | ▲ Buy | Grant | 20,034 | $0 | 8/7/2026 |
| Germano Geno J | ▲ Buy | Grant | 25,014 | $0 | 8/7/2026 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 347,567 | $0 | 7/14/2026 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 72,993 | $0 | 7/14/2026 |
| Galitzer Hillel | ▲ Buy | Grant | 72,993 | $0 | 5/7/2026 |
| Yaacov-Garbeli Dana | ▲ Buy | Grant | 58,394 | $0 | 5/7/2026 |
| Burshtein Gregory | ▲ Buy | Grant | 87,591 | $0 | 5/7/2026 |
| Germano Geno J | ▲ Buy | Open Market | 20,000 | $26K | 3/9/2026 |
| Ellis Sean | ▲ Buy | Open Market | 10,000 | $12K | 3/5/2026 |
| Steven D. Rubin | ▲ Buy | Open Market | 5,000 | $7K | 2/12/2026 |
| Taitel Haya | ▲ Buy | Open Market | 7,500 | $11K | 2/10/2026 |
| Germano Geno J | ▲ Buy | Open Market | 20,000 | $30K | 2/10/2026 |
| Steven D. Rubin | ▲ Buy | Open Market | 10,000 | $12K | 2/9/2026 |
| Ellis Sean | ▲ Buy | Open Market | 18,000 | $22K | 2/9/2026 |
| Malca Yonatan | ▲ Buy | Grant | 30,157 | $0 | 1/1/2026 |
| Taitel Haya | ▲ Buy | Grant | 26,329 | $0 | 1/1/2026 |
| Gerald M. Lieberman | ▲ Buy | Grant | 38,294 | $0 | 1/1/2026 |
| OSTROV GERALD M | ▲ Buy | Grant | 28,721 | $0 | 1/1/2026 |
| Ellis Sean | ▲ Buy | Grant | 25,371 | $0 | 1/1/2026 |
| Miranda Jayne Toledano | ▲ Buy | Open Market | 11,000 | $20K | 12/29/2025 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 136,842 | $0 | 7/16/2025 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 43,860 | $0 | 7/16/2025 |
| Yaacov-Garbeli Dana | ▲ Buy | Grant | 26,316 | $0 | 7/16/2025 |
| Burshtein Gregory | ▲ Buy | Grant | 26,316 | $0 | 7/16/2025 |
| Galitzer Hillel | ▲ Buy | Grant | 26,316 | $0 | 4/28/2025 |
| Gerald M. Lieberman | ▲ Buy | Option Exercise | 23,952 | $24K | 4/1/2025 |
| Taitel Haya | ▲ Buy | Grant | 6,922 | $0 | 1/15/2025 |
| OSTROV GERALD M | ▲ Buy | Grant | 8,038 | $0 | 1/15/2025 |
| Malca Yonatan | ▲ Buy | Grant | 8,216 | $0 | 1/15/2025 |
| Gerald M. Lieberman | ▲ Buy | Grant | 10,717 | $0 | 1/15/2025 |
| Ellis Sean | ▲ Buy | Grant | 7,100 | $0 | 1/15/2025 |
| Taitel Haya | ▲ Buy | Grant | 7,278 | $0 | 10/2/2024 |
| OSTROV GERALD M | ▲ Buy | Grant | 8,452 | $0 | 10/2/2024 |
| Malca Yonatan | ▲ Buy | Grant | 8,639 | $0 | 10/2/2024 |
| Gerald M. Lieberman | ▲ Buy | Grant | 11,269 | $0 | 10/2/2024 |
| Ellis Sean | ▲ Buy | Grant | 7,466 | $0 | 10/2/2024 |
| OSTROV GERALD M | ▲ Buy | Grant | 20,446 | $0 | 8/27/2024 |
| Taitel Haya | ▲ Buy | Grant | 15,335 | $0 | 8/27/2024 |
| Ellis Sean | ▲ Buy | Grant | 18,061 | $0 | 8/27/2024 |
| Malca Yonatan | ▲ Buy | Grant | 23,172 | $0 | 8/27/2024 |
| Gerald M. Lieberman | ▲ Buy | Grant | 27,261 | $0 | 8/27/2024 |
| Miranda Jayne Toledano | ▲ Buy | Grant | 124,121 | $0 | 7/31/2024 |
| Yaacov-Garbeli Dana | ▲ Buy | Grant | 30,151 | $0 | 4/19/2024 |
| Galitzer Hillel | ▲ Buy | Grant | 30,151 | $0 | 4/19/2024 |
| Taitel Haya | ▲ Buy | Open Market | 9,500 | $9K | 1/12/2024 |
| Taitel Haya | ▲ Buy | Open Market | 7,615 | $6K | 1/10/2024 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 23,952 | $17K | 12/22/2023 |
| Miranda Jayne Toledano | ▲ Buy | Open Market | 23,952 | $17K | 12/22/2023 |
| Taitel Haya | ▲ Buy | Open Market | 18,000 | $11K | 8/22/2023 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 20,000 | $12K | 8/21/2023 |
| Ellis Sean | ▲ Buy | Open Market | 40,000 | $24K | 8/21/2023 |
| Miranda Jayne Toledano | ▲ Buy | Open Market | 30,000 | $30K | 4/4/2023 |
| Yaacov-Garbeli Dana | ▲ Buy | Open Market | 26,580 | $14K | 11/14/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 34,000 | $19K | 11/14/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 4,000 | $2K | 11/14/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 4,000 | $2K | 11/14/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 4,000 | $2K | 11/14/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 4,000 | $2K | 11/14/2022 |
| Yaacov-Garbeli Dana | ▲ Buy | Open Market | 30,000 | $16K | 11/11/2022 |
| Miranda Jayne Toledano | ▲ Buy | Open Market | 50,000 | $27K | 11/11/2022 |
| Ellis Sean | ▲ Buy | Open Market | 30,000 | $16K | 11/11/2022 |
| Ellis Sean | ▲ Buy | Open Market | 14,900 | $24K | 7/21/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 19,491 | $33K | 7/21/2022 |
| Schwartz Phillip | ▲ Buy | Open Market | 10,000 | $25K | 1/20/2022 |
| Ratan Ramesh | ▲ Buy | Open Market | 10,000 | $24K | 1/19/2022 |
| JAMAS SPIROS | ▲ Buy | Open Market | 10,000 | $29K | 1/18/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 700 | $2K | 1/18/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 700 | $2K | 1/18/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 700 | $2K | 1/18/2022 |
| Gerald M. Lieberman | ▲ Buy | Open Market | 700 | $2K | 1/18/2022 |
| Mayron Ron | ▲ Buy | Open Market | 7,000 | $20K | 1/18/2022 |
| Ellis Sean | ▲ Buy | Open Market | 10,000 | $28K | 1/18/2022 |
| Miranda Jayne Toledano | ▲ Buy | Open Market | 6,800 | $19K | 1/14/2022 |
| OSTROV GERALD M | ▲ Buy | Open Market | 10,000 | $27K | 1/13/2022 |
| Malca Yonatan | ▲ Buy | Open Market | 7,232 | $20K | 1/13/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Entera Bio gets new coverage from Guggenheim and Cantor
Guggenheim has started coverage of Entera Bio, giving it a buy rating and a target price of $11. Cantor Fitzgerald also began coverage, assigning an overweight rating. These new ratings come as the stock trades near its 52‑week low and shows a moderate RSI of 40, indicating room for movement.
Entera Bio gets new coverage from Guggenheim and Cantor. Guggenheim has started coverage of Entera Bio, giving it a buy rating and a target price of $11. Cantor Fitzgerald also began coverage, assigning an overweight rating. These new ratings come as the stock trades near its 52‑week low and shows a moderate RSI of 40, indicating room for movement.